UCB S.A. NPV revenue breakdown overview

UCB S.A. NPV revenue for the last year amounted to 5.25 B EUR, the most of which — 4.87 B EUR — came from its highest performing source at the moment, Biopharmaceuticals, the year earlier bringing 5.14 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought UCB S.A. NPV 2.45 B EUR, and the year before that — 2.90 B EUR.